The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
FOLLOWING a whirlwind year of acquisitions, fund raises and a debut on the NASDAQ stock exchange, IM Cannabis (IMC) is
MGC Pharma has received approval for a dose finding study for its proprietary treatment for the effects of COVID-19.
MGC Pharma has signed a Supply and Distribution Agreement with AMC Holdings.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in
The company’s experimental treatment for severe epilepsy will be covered by the health service.
Two medical patients have revealed the role the treatment has played in their lives at an industry conference.
Danish politicians have agreed to extend a medical cannabis programme – and North America’s giants are watching
Canadian company Zyus’ deal to enter Portugal is another indication the global industry is watching Europe
How an Israel-based company made history by listing on the London Stock Exchange
A Canadian firm is trialing a synthetic cannabinoid treatment for a common pet health issue
It has a world famous reputation among cannabis users – but a decades old problem
Plans for a large medical cannabis facility near Dumfries have been backed by investors
The Australia-based company has reported record sales of its pharmaceutical products
Policymakers are being asked to rethink the UK’s approach to cannabis-derived treatments
The UK is a major producer of medical cannabis – so why are prescriptions still so rare?
Irish medical cannabis campaigner Vera Twomey has called on the Government to change course on drug policy and lead a
We won’t spam you
